CIK 0001551152
- Large accelerated filer
AbbVie Inc.
Sign in to watch- Ticker
- ABBV
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320375147
- Phone
- +1 847-932-7900
- Business address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,925,738
- in 1 filing
Net −$11,925,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-30 | Alpern Robert J Director | Grant or award · Stock Equivalent Units | +55 | $134.73 | $7K | 9,001 |
| 2023-05-11 | Strom Carrie C SVP & PRES GLOBAL ALLERG AESTH | Shares withheld for taxes | −2,876 | $146.42 | $421K | 28,024 |
| 2023-05-05 | WADDELL FREDERICK H Director | Grant or award | +1,450 | 26,433 | ||
| 2023-05-05 | TILTON GLENN F Director | Grant or award | +1,450 | 49,039 | ||
| 2023-05-05 | Roberts Rebecca B Director | Grant or award | +1,450 | 11,203 | ||
| 2023-05-05 | RAPP EDWARD J Director | Grant or award | +1,450 | 30,034 | ||
| 2023-05-05 | MEYER MELODY B Director | Grant or award | +1,450 | 13,973 | ||
| 2023-05-05 | Hart Brett J Director | Grant or award | +1,450 | 16,947 | ||
| 2023-05-05 | AUSTIN ROXANNE S Director | Grant or award | +1,450 | 35,933 | ||
| 2023-05-05 | FREYMAN THOMAS C Director | Grant or award | +1,450 | 124,226 | ||
| 2023-05-05 | BURNSIDE WILLIAM H.L. Director | Grant or award | +1,450 | 24,433 | ||
| 2023-05-05 | Alpern Robert J Director | Grant or award | +1,450 | 32,992 | ||
| 2023-04-28 | TILTON GLENN F Director | Option exercise · Stock Equivalent Units | −2,230 | $151.12 | $337K | 34,700 |
| 2023-04-25 | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS | Option exercise 10b5-1 | +6,130 | $144.54 | $886K | 41,460 |
| 2023-04-25 | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS | Sale 10b5-1 | −6,130 | $165.00 | $1.0M | 35,330 |
| 2023-04-25 | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS | Option exercise · Option (Right to Buy) 10b5-1 | −6,130 | $144.54 | $886K | 12,258 |
| 2023-04-17 | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS | Sale 10b5-1 | −6,999 | $161.64 | $1.1M | 35,830 |
| 2023-04-17 | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS | Sale 10b5-1 | −500 | $162.04 | $81K | 35,330 |
| 2023-04-03 | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS | Option exercise | +15,002 | $93.50 | $1.4M | 57,831 |
| 2023-04-03 | Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS | Sale | −15,002 | $160.03 | $2.4M | 42,829 |
Page 20 of 23 · 457 trades